_edited_edited.png)
ICON
International Cancer Opinion Network
About ICON
ICON – International Cancer Opinion Network provides independent,
evidence-based second opinions for patients with complex cancer diagnoses and treatment decisions.
As oncology rapidly evolves with advances in molecular diagnostics, targeted therapies, immunotherapy, and multidisciplinary care treatment choices have become more complex. ICON offers a structured review of medical records, pathology, and imaging
to help patients better understand their diagnosis and available treatment options.
It is an independent medical advisory service and is not affiliated with any hospital, clinic, or similarly named organization. This service is for advisory purposes only and does not replace in-person medical care.
About the Founder
Dr. Omid Modiramani, MD
Medical Oncologist & Hematologist
Dr. Omid Modiramani, Founder of ICON, is a board-certified medical oncologist and hematologist with over 14 years of clinical experience in the comprehensive management of cancer.
His clinical work has encompassed a broad spectrum of solid tumors, including but not limited to:
-
Breast malignancies
-
Thoracic Oncology
-
Gastrointestinal and hepatobiliary cancers
-
Genitourinary Oncology
-
Gynecologic malignancies
-
Neuroendocrine tumors
-
Central nervous system tumors
-
Head and neck cancers
-
Cutaneous and endocrine malignancies
-
Bone and rare tumors
Throughout his career, Dr. Modiramani has been deeply engaged in the integration of evidence-based oncology into daily clinical decision-making. His work emphasizes:
-
Critical appraisal of clinical trials
-
Guideline-based treatment strategies
-
Multidisciplinary tumor board collaboration
-
Individualized systemic therapy planning
-
Risk–benefit assessment in complex cases
He has reviewed and managed thousands of oncology cases across diverse clinical settings, with particular attention to diagnostic accuracy, therapeutic sequencing, and long-term treatment strategy.
Through ICON, Dr. Modiramani provides independent second opinion advisory services based exclusively
on submitted medical records, pathology, imaging, and treatment documentation.
Dr. Omid Modiramani is an active member of leading international oncology societies, including:
-
International Society for Telemedicine & eHealth (ISfTeH)
-
American Society of Clinical Oncology (ASCO)
-
European Society for Medical Oncology (ESMO)
Through these memberships, he remains engaged with ongoing advancements in clinical research, emerging therapies, and evolving international oncology guidelines.
Participation in major oncology congresses and scientific updates supports his commitment to evidence-based, up-to-date clinical advisory practice.
Dr. Modiramani remains actively engaged in international oncology research, clinical updates, and guideline-based cancer care to ensure that advisory opinions reflect current scientific standards
Directly With Medical Oncologist
Clinical Philosophy
Scientific Precision
Every advisory opinion is grounded in current international oncology standards, peer-reviewed literature, and contemporary treatment guidelines.
Multidisciplinary Perspective
Cancer care is inherently multidisciplinary. Advisory review considers surgical, medical, radiation, and systemic therapeutic implications in a comprehensive framework.
Individualized Evaluation
Each patient case is unique. Advisory opinions are tailored to the clinical context, disease stage, biological characteristics, and patient-specific considerations.
Ethical Responsibility
The advisory process is conducted with professional integrity, objectivity, and respect for the primary treating physician’s role.